Objective: To determine the effect of high-protein diets, which have recently been promoted for their health benefits, on urinary calcium losses and bone turnover in older subjects. Design: Randomized controlled cross-over study. Setting: Teaching hospital and university. Subjects: Twenty hyperlipidemic men and postmenopausal women (age 56 AE 2 y) completed the study. Intervention: One-month test and control phases during which subjects consumed equi-energy metabolic diets high in calcium (1578 and 1593 mg=day, respectively). On the test diet 11% of total dietary energy from starch in the control bread was replaced by protein (wheat gluten), resulting in 27% of energy from protein on the test diet vs 16% on the control diet. Main outcome measure: Urinary calcium excretion. Results: Compared with the control diet, at week 4, the test diet increased mean ( AE s.e.m.) 24 h urinary output of calcium (139 AE 15 vs 227 AE 21 mg, P ¼ 0.004). The treatment difference in urinary calcium loss correlated with the serum anion gap as a marker of metabolic acid production (r ¼ 0.57, P ¼ 0.011). Serum calcium levels were marginally lower 2.41 AE 0.02 vs 2.38 AE 0.02 mmol=l (P ¼ 0.075), but there was no significant treatment difference in calcium balance, possibly related to the high background calcium intake on both diets. Conclusion: In the presence of high dietary calcium intakes the vegetable protein gluten does not appear to have a negative effect on calcium balance despite increased urinary calcium loss.
Introduction
High-protein diets have been promoted for health, especially in the context of weight loss and subsequent weight maintenance (Atkins, 1992; Sears & Lawren, 1995; Eades & Eades, 1996; Steward et al, 1998) . Furthermore moderate increases in protein intake have been associated with a reduced risk of cardiovascular disease (CHD) in large cohort studies (Hu et al, 1999) . Nevertheless, sustained use of high animal protein diets has been questioned in relation to risk factors for cardiovascular disease due to the relatively high proportion of saturated fat and cholesterol which these diets may contain (Anderson et al, 2000) . In some popular diets, protein intakes, mostly from animal sources, range from 25 to 38% of calories (Atkins, 1992; Sears & Lawren, 1995; Eades & Eades, 1996; Steward et al, 1998) , which is much higher than the 10 -20% advised by most government and health-related agencies (US Department of Health and Human Services, 1988; Health and Welfare Canada, 1990; USDA, 1992; NCEP, 1993 ; American Diabetes Association and The American Dietetic Association, 1995; National Nutrition Committee CDA, 1999) . There is also concern that, by promoting urinary calcium loss, very high protein diets may increase the risk of osteoporosis in susceptible individuals (Massey, 1998) . Related to this concern, some cohort studies have suggested that high-protein diets are associated with increased risk of fractures (Feskanich et al, 1996; Sellmeyer et al, 2001) , while others have not (Hannan et al, 2000) .
Many of the studies assessing the effects of high-protein diets on calcium loss have involved healthy young subjects and have been of relatively short duration (Heaney, 1998; Massey, 1998) . Longer studies are required in older subjects, especially those with risk factors for chronic disease, who may wish to use high-protein diets but may be less physiologically adaptable (Massey, 1998) . We have therefore examined the effect of increased vegetable protein intake on urinary and fecal calcium losses in middle-aged men and post-menopausal women with hyperlipidemia. We used a vegetable protein, gluten, which is not associated with saturated fat, but which has a favorable effect on blood lipids (Jenkins et al, 2001 ). On the high-protein diet, protein contributed 27% of total calories, which was at the lower end of the range recommended in popular diet books (Atkins, 1992; Sears & Lawren, 1995; Eades & Eades, 1996; Steward et al, 1998) .
Methods
Twenty subjects (15 men and five women), mean (s.d.) age 56 AE 8.5 y (range 35 -71 y) body mass index (BMI) 26.0 AE 3.1 kg=m 2 (range 20.3 -31.2 kg=m 2 ) completed a crossover study involving high vegetable protein and control metabolic diets each of one-month duration. There was a washout period between diets of at least 2 weeks with the exception of one subject whose washout period was one week. This study was part of a broad assessment of the effects of high-protein diets on risk factors for chronic disease. Data on serum lipids, urea and creatinine clearance have been reported previously (Jenkins et al, 2001 ). The treatment order was not randomized. The first 10 subjects started on control in the first phase and the second 10 subjects started first on the highprotein diet. All subjects previously had high concentrations of low-density-lipoprotein cholesterol (LDL-C > 4.1 mmol=l; NCEP, 1993) and had been instructed on a National Cholesterol Education Program (NCEP) Step 2 diet at least 2 months prior to starting the study (total fat < 30% of calories, saturated fat < 7% and dietary cholesterol < 200 mg=day). Prior to the start of the study their mean protein intake as a percentage of energy was 18% with a calcium intake of 783 mg=day. At the start of the study four subjects had both increased serum LDL cholesterol and increased serum triglyceride ( > 2.3 mmol=l), 8 had an increased LDL cholesterol alone, five had an increased triglyceride alone and three were normolipidemic. All the women were at least 2 y postmenopausal. Subjects had no clinical evidence of cardiovascular disease, diabetes, liver or renal disease. None were taking lipid-lowering medications, hormone replacement therapy or L-thyroxine. No subjects were taking calcium supplements with the exception of one man who took a mineral supplement (600 mg calcium). One subject was on a b-blocking agent and two took angiotensin-converting enzyme inhibitors. All medications were held constant throughout the study periods. Subjects were asked to maintain the same level of physical activity throughout the study.
During metabolic periods, subjects were provided with all food to be consumed in prepackaged form, delivered by courier at weekly intervals. Also at weekly intervals, subjects came fasting to the Clinical Nutrition and Risk Factor Modification Center where they were weighed and had their blood pressure measured by the same observer after being seated for 15 min. Dietary compliance was assessed on the basis of returned uneaten items and menu plans on which the subjects recorded the amount of all items eaten. When necessary, diets were adjusted to avoid weight change. At baseline and at the end of weeks 2 and 4 of each metabolic phase, fasting blood was obtained and at the end of week 4 each subject collected their 24 h urinary output in a 4 l plastic container with no preservative added. Also during week 4, feces were collected for a 3 day period using underseat lavatory frames with suspended plastic bags. After use, bags were sealed, labelled and stored on frozen CO 2 in a polystyrene container, which was transported by courier to the laboratory on completion of the collection.
Diets
The diets on both phases were identical apart from the bread, which constituted approximately 18% of the total energy intake for each subject. The macronutrient composition of the control bread as a percentage of energy was 1.3% protein, 8.1% fat and 90.7% available carbohydrate, with 1.55 g fiber=MJ (6.5 g fiber=1000 kcal) and supplied 20 mg=day calcium, 12 mg=day magnesium, 160 mg=day sodium, 85 mg=day potassium, 19 m=day sulfur and 131 mg=day phosphorus. The respective figures for the test (high-protein) bread were 50.4% protein, 7.0% fat and 42.6% available carbohydrate, with 1.24 g fiber=MJ (5.2 g fiber=1000 kcal), 46 mg=day calcium, 46 mg=day magnesium, 1389 mg=day sodium, 114 mg=day potassium, 875 mg=day sulfur and 249 mg=day phosphorus. The macronutrient composition of the control and test (high protein) diets is given in Table 1 . For the metabolic diet, energy intake was assessed for weight maintenance using standard tables (The Lipid Research Clinics, 1982) with adjustment for the High-protein diets and urinary calcium loss DJA Jenkins et al subjects' physical activity and pre-study 7 day diet history. Diets were devised and dietary intakes calculated using a database in which the majority of foods had been analyzed by Association of Official Analytical Chemists (1980) methods for fat, protein and fiber (Prosky et al, 1985) with available carbohydrate estimated by difference. The fatty acid composition was determined by gas chromatography (Cunnane et al, 1995) . The food composition tables of the US Department of Agriculture (Agriculture Research Service, 1992) and food labels were used for foods that had not been analyzed directly.
Analyses

Serum was stored at 770
C and all samples from a given subject were analyzed in a single batch. Serum was analyzed for albumin, creatinine, calcium, magnesium, electrolytes, phosphate, bicarbonate and total alkaline phosphatase (Vitros 950, Ortho Clinical Diagnostics, Rochester, NY, USA). Measurements were made in serum of bone-specific alkaline phosphatase by an ELISA technique using a monoclonal antibody (Metra Biosystems, Palo Alto, CA, USA), 25-hydroxy-vitamin D by radioimmuno-assay (DiaSorin, Stillwater, MN, USA) and parathyroid hormone by an immunoradiometric assay (IRMA) using two polyclonal antibodies (DiaSorin, Stillwater, MN, USA).
Twenty-four hour urine collections were measured for volume, divided into aliquots and stored at 770 C prior to analysis. N-telopeptide, as a collagen-derived marker of bone turnover, was measured in urine by an ELISA technique (Ostex, Seattle, WA, USA). Urinary creatinine, calcium, magnesium and electrolytes with bicarbonate as total CO 2 were also measured in the hospital's clinical biochemistry laboratory by an autoanalyzer technique (Vitros 950, Ortho Clinical Diagnostics, Rochester, NY, USA). Creatinine clearance was calculated (Table 3 ) and the results have been reported previously (Jenkins et al, 2001) .
Partially thawed 3 day fecal collections for all subjects and a 7 day diet composite (representing 2800 kcal diet) were homogenized in a blender and 300 g aliquots were freezedried. Calcium, magnesium, sodium and potassium were analyzed in the freeze-dried fecal and diet samples by an induction-coupled plasma (ICP) optical emission spectrometer (Varian Vista-Pro Spectrometer with a charge coupled device (CCD) detector; Varian, Mississauga, ON, Canada).
Statistical analysis
The results are expressed as means AE s.e.m.s. Treatment differences were assessed by analysis of covariance using the General Linear Model procedure (PROC GLM=SAS) with endof-treatment value as the response variable and the following main effects: diet, diet-by-sex interaction to assess possible sex differences in response, treatment order (sequence) to verify the effectiveness of the randomization, a random term due to subject nested within the sex-by-sequence interaction to define the crossover nature of the design, and baseline as a covariate as a potential determinant of the magnitude of the treatment effect (SAS Institute, 1997). Paired two-tailed Student's t-tests were also used to assess the significance of the percentage difference between end values for the two treatments. Week 4 test and control values were compared where the control value was expressed as 100% and the difference between test and control was the basis for the paired t-test. Mineral balance was calculated as the mean daily dietary intake in milligrams minus the losses in urine and feces in milligrams per day. Pearson correlations were used to assess the association of treatment differences in urinary calcium output and other serum and urinary measurements (SAS Institute, 1997).
Results
Compliance was satisfactory for both treatments. On the control diet, subjects consumed 96.4 AE 0.9% of the dietary energy provided and, on the high-protein diet, 93.4 AE 1.7%. Compliance for bread consumption was 98.6 AE 1.0% on the control and 97.5 AE 1.0% on the test diet. There were no significant differences in change in body weight between treatments (Table 2) . At the end of the metabolic study (mean AE s.e.m.) body weights were 75.9 AE 3.1 kg on the control diet and 75.9 AE 3.0 kg on the high-protein diet. High-protein diets and urinary calcium loss DJA Jenkins et al Significance of end treatment difference between high-protein and control phases assessed using the general linear model in SAS (SAS Institute Inc., 1997); *P < 0.05; **P < 0.01; ***P < 0.001.
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Serum measurements
Serum calcium was marginally lower on the high-protein diet by comparison with the control diet (0.9 AE 0.5%, P ¼ 0.070), as was parathyroid hormone (9.4 AE 4.7%, P ¼ 0.058); (Table 2 ). The marginal significance of the absolute reduction in calcium was confirmed using the general linear model procedure (P ¼ 0.075), but not the absolute reduction in parathyroid hormone (P ¼ 0.252). No differences were seen between treatments in serum phosphate, albumin, total alkaline phosphatase, bone specific alkaline phosphatase or 25-hydroxy-vitamin D (Table 2 ). The serum levels on high protein and control diets were also similar for electrolytes -sodium, potassium, chloride and bicarbonate (Table 2) .
Urinary measurements
Urine volumes were similar over 24 h for both treatments, as were 24 h urinary creatinine outputs and creatinine clearance (Table 3) . However, on the high-protein diet there was an increase in 24 h urinary excretion of calcium (81 AE 16%, P < 0.001); magnesium (63 AE 20%, P ¼ 0.006); sodium (31 AE 11%, P ¼ 0.013); chloride (31 AE 11%, P ¼ 0.011) and N-telopeptide (59 AE 25%, P ¼ 0.029) by comparison with the control diet ( Table 3 ). The significance of these differences was confirmed for the absolute values after creatinine correction using the general linear model, for calcium (P ¼ 0.004) and chloride (P ¼ 0.049). For the remainder the absolute differences did not reach significance (magnesium, P ¼ 0.091; sodium, P ¼ 0.064; and N-telopeptide, P ¼ 0.155).
Fecal measurements and mineral balance
No treatment differences were seen in fecal mineral output (Table 3 ). There was a tendency for reduced calcium and magnesium outputs on the high-protein diet, but these were not significant. There were no differences in mineral balance between treatments (Table 3) .
Relationships between urinary calcium and other measurements The treatment difference in urinary calcium losses was significantly related to the treatment differences in serum anion gap (r ¼ 0.57, P ¼ 0.011), serum bicarbonate (r ¼ 70.47, P ¼ 0.042), and urinary urea output as an indicator of protein intake (r ¼ 0.68, P ¼ 0.001), and approached significance for the treatment difference in urinary N-telopeptide output (r ¼ 0.43, P ¼ 0.065). There was no relation with the treatment difference in serum calcium (r ¼ 0.06, P ¼ 0.796).
Blood pressure
No treatment difference in blood pressure was noted between diets. No differences were seen between the sexes in response to treatment.
Discussion
The high-protein diet resulted in a significant increase in urinary calcium loss together with a greater urinary output of N-telopeptide. These findings are consistent with studies of shorter duration, suggesting increased bone turnover on high-protein diets (Massey, 1998) . At current calcium intakes in the population, sustained calcium losses of this magnitude, secondary to high-protein diets, may increase the risk of osteoporosis unless compensated for by corresponding increases in calcium intake or reduction in fecal losses. In the present study average calcium intakes were high at over 1.5 g=day and increased protein intake had no effect on calcium balance. The relation between protein intake and urinary calcium loss appears to be linear. It has been estimated that a doubling in protein intake will result in an approximately 50% increase in urinary calcium loss (Hannan et al, 2000) . Our subjects were older than many that have been studied and had at least one risk factor for chronic disease, namely raised serum cholesterol. Their calcium losses were almost double those predicted from their protein intake (Heaney, 1998) . This raises the question of whether vulnerability increases with age or infirmity. This increase is of particular importance since individuals who are older and at increased risk for chronic disease may be tempted to try unconventional ways to lose weight. Our subjects had an average body mass index (BMI) of 26 kg=m 2 and by current standards 19 would be classified as overweight (BMI > 25 kg=m 2 ) and two as obese (BMI > 30 kg=m 2 ) and accordingly would be advised to lose weight (National Institutes of Health, 1998) . The outcome in terms of bone health would therefore depend largely on the calcium content of the protein source, in view of the sub-optimal calcium intake on most Western diets.
The mechanism by which protein induces a loss of calcium is considered to relate to the potential renal acid load created by the metabolism of protein, yielding phosphate and sulfate. Bone buffers these acids by releasing carbonate, citrate and sodium from the hydration shell surrounding the bone. In the chronic state calcium is mobilized to buffer the acid load (Barzel & Massey, 1998) , although recent studies have challenged the purported effect of phosphoric acid to augment urinary calcium loss (Heaney & Rafferty, 2001 ). It has also been suggested that the elderly have a reduced ability to excrete an acid load based on lower blood pH and bicarbonate levels (Frasetto & Sebastian, 1996) . It is therefore of interest that the increased calcium loss associated with the higher protein intake related to the anion gap as an indicator of increased acidic metabolites in the serum. Frassetto et al (1998) and Lemann (1999) have proposed using the ratio of dietary protein to potassium and urinary urea to potassium, respectively, as indices of net endogenous acid production. Although the former did not relate to urinary calcium loss, the latter showed borderline significance (r ¼ 0.42, P ¼ 0.064). The requirement for additional calcium to buffer an acid load may therefore have contributed to the increased urinary losses of calcium seen in High-protein diets and urinary calcium loss DJA Jenkins et al our hyperlipidemic middle aged subjects. Similar calcium losses have been reported in the elderly when protein intakes were doubled (Licata et al, 1981) . Several studies have shown that provision of base as bicarbonate can remove or reduce the negative calcium balance induced by dietary protein (Licata et al, 1981; Sebastian et al, 1994) . Fruit and vegetables are major natural sources of buffer in the diet. In our study the large increase in urinary calcium loss was seen despite significant intakes of fruit and vegetables (6 -8 servings per 2500 kcal) in the background diet of both phases. In the present study the high sulfur content of the gluten bread was enough to account for more than an order of magnitude greater urinary calcium loss (27 mmol=day) between treatments than actually observed (2 mmol=day), assuming all the sulfur was converted to sulfate and excreted in the urine. Associated with the gluten, the test diet provided an additional 1.16 g of sodium daily, which would contribute to the increased urinary calcium loss. Based on the data of Ginty et al (1998) , who increased their subjects' sodium intakes by 2.3 g=day, we would predict that our increase in sodium intake would account for 17% of the 81% increase in calcium loss observed in our study.
Homeostatic mechanisms will also tend to limit calcium loss. A fall in extracellular calcium ion increases secretion of parathyroid hormone (PTH), which in turn promotes 1a-hydroxylation of 25-hydroxy-cholecalciferol (25[OH]-D 3 ) in the kidney and hence increased absorption of dietary calcium from the gut. On the high-protein diet serum calcium levels tended to be lower and fecal calcium losses were marginally reduced. However, PTH levels were also somewhat lower on the high protein diet. We have no explanation for this phenomenon since serum calcium concentrations were not increased. Nevertheless PTH levels were reported to be increased on low-protein diets fed to young women while a high-protein diet tended to suppress PTH at 14 days (Kerstetter et al, 1999) . Although 1,25(OH) 2 -D 3 levels were not measured, in view of the depressed PTH levels it seems unlikely that increased hydroxylation of vitamin D was responsible for any increase in calcium absorption as reflected in reduced fecal calcium losses.
An alternative explanation is that high protein intakes may promote mineral absorption by a direct effect in the gastrointestinal tract (Kerstetter et al, 1998; Bennett et al, 2000) . Although this effect has been contested (Heaney, 2000) , increased calcium absorption would result in a corresponding increase in urinary calcium output to maintain calcium balance. In our studies the magnitude of the calcium intake and resulting large fecal loss made it difficult to detect the proportionally small percentage difference (11%) in fecal calcium output. The 11% difference in fecal calcium loss was more than enough to account for the relatively large percentage increase in urinary calcium loss (80%). However the increased output of N-telopeptide supports mobilization of bone calcium as part of the explanation for the increase in urinary calcium output on high-protein diets. Against this conclusion is the lack of effect on PTH concentrations. This discrepancy makes interpretation of the direct effect of gluten on bone in our study difficult. The exact extent to which increased calcium absorption also contributed to increased urinary loss remains to be determined.
These data therefore do not provide clear evidence of a deleterious effect of high-protein intake on calcium balance when calcium intakes are high (1.6 g=day). The protein effects on magnesium mirrored the effects on calcium with increased urinary losses but with no change in magnesium balance as has been found in other studies (Mahalko et al, 1983; Lutz & Linkswiler, 1981) .
In conclusion, high vegetable protein intake significantly increased urinary calcium and magnesium losses. In the presence of high dietary calcium intakes, the vegetable protein gluten does not appear to have a negative effect on calcium balance. The situation may be different with more acidic animal proteins (eg containing more phosphorous) at low calcium intakes where the increased urinary calcium losses may not be so readily compensated for.
